Key result
Structural studies of the influenza RNA polymerase PA subunit endonuclease domain reveal how the enzyme binds RNA and DNA substrates and how baloxavir resistance mutations maintain viral fitness.
Why the study?
Baloxavir is associated with resistance mutations threatening its clinical efficacy, requiring an understanding of the endonuclease specificity and the structural basis of these mutations.
Structural insights into PAN-oligonucleotide binding may guide baloxavir resistance countermeasures; leaves open clinical translation without functional validation.
The endonuclease activity within the influenza virus cap-snatching process is a proven therapeutic target. The anti-influenza drug baloxavir is highly effective, but is associated with resistance mutations that threaten its clinical efficacy. The endonuclease resides within the N-terminal domain of the PA subunit (PAN) of the influenza RNA dependent RNA polymerase, and we report here complexes of PAN with RNA and DNA oligonucleotides to understand its specificity and the structural basis of baloxavir resistance mutations. The RNA and DNA oligonucleotides bind within the substrate binding groove of PAN in a similar fashion, explaining the ability of the enzyme to cleave both substrates. The individual nucleotides occupy adjacent conserved pockets that flank the two-metal active site. However, the 2' OH of the RNA ribose moieties engage in additional interactions that appear to optimize the binding and cleavage efficiency for the natural substrate. The major baloxavir resistance mutation at position 38 is at the core of the substrate binding site, but structural studies and modeling suggest that it maintains the necessary virus fitness via compensating interactions with RNA. These studies will facilitate the development of new influenza therapeutics that spatially match the substrate and are less likely to elicit resistance mutations.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2020) studied Influenza virus. Structural analysis of PAN complexes with RNA and DNA oligonucleotides was evaluated on Substrate specificity and structural basis of baloxavir resistance mutations. Structural studies of the influenza RNA polymerase PA subunit endonuclease domain reveal how the enzyme binds RNA and DNA substrates and how baloxavir resistance mutations maintain viral fitness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: